With over 40 years of experience in both large pharmaceutical businesses and across the generics industry, Alan guides the mission and vision of the Colonis team, maintaining a clear commercial strategy for its continued growth in the value-added medicines market.
Aleena recently joined Colonis, bringing over 6 years’ experience in pharmacovigilance (PV) across both service provider and MAH environments. At Colonis, Aleena oversees PV, managing the PV governance and oversight framework, supporting regulatory compliance, and developing our in-house PV capabilities.
Andreea joined Colonis in 2023 as our Quality Assurance Officer. With a background supporting Pharmaceutical Quality, she specialises in overseeing the compliance (GMP/GDP) of training and documentation related activities associated with our drug product range across the business. Andreea also supports the vendor management process alongside communications with suppliers, internal and external customers related to quality issues.
Andrew has been the Quality Lead for Colonis’ value-added medicines portfolio since 2019, overseeing UK, EU, and RoW markets. With over 30 years of international pharmaceutical quality control experience, Andrew brings extensive expertise to his role, working closely with his team to oversee the compliance of products throughout their lifecycle and ensure safe, continuous medicine supply to patients.
Derek joined Colonis in 2023 as National Account Manager, overseeing UK commercial activities and strategy of the Colonis portfolio. He brings with him 12 years of pharmaceutical industry experience in the retail and hospitals sectors, promoting generic and branded generic medicines across numerous therapy areas including Oncology, Anti-infectives, Cardiovascular, Respiratory and Pain.
Georgia joined Colonis in 2025 as ourAlliance Manager. She holds a degree in Biological Sciences and has over three years of pharmaceutical industry experience in commercial operations, strategy and alliance management. She is responsible for the management of Colonis’ international partner network and execution of international product launches.
Henning Thiel– International Business Development Manager
Bringing over 20 years of experience in global business development, licensing, and international market expansion, Henning has led international licensing initiatives and developed EU internationalisation strategies. Based inGermany, Henning focuses on our in-licensing strategy across the UK and EU.
Ipek joins the Colonis team as our Marketing Associate. With a background in pharmaceutical marketing focused on brand management and strategic planning, she has established experience of executing marketing campaigns, coordinating with cross-functional teams and leading KOL engagement.
With over 30 years of experience within the pharmaceutical industry, Melinda recently joinedColonis as our Marketing Manager. Melinda brings her marketing and commercial expertise from across the UK and international regions to Colonis.
Michael joined Colonis as Commercial Director in 2014. With 12 years of pharmaceutical industry experience across various roles in commercial, marketing, and product management, he currently oversees the global commercial strategy for the Colonis business.
Narendra Patel
– New Product Business Development Manager
Narendra joined the Colonis team as New Product Business Development Manager in 2021. With over 12 years of pharmaceutical experience, he specialises in value-added portfolio planning and licensing and holds degrees in Pharmacy, Pharmaceutical Science and an MBA.
Patty Efraimidou – Finance and Operations Director
With over 20 years of financial experience, Patty joined Colonis as Finance Director in 2017. In her day-to-day role, Patty directs and oversees all aspects of the finance and accounting functions, from supporting the management team in maximising assets and investments, to providing robust and insightful support on key business decisions.
With over 30 years of experience in procurement and supply chain, Penny has been with Colonis since 2005. Her expertise lies across clinical trial procurement, unlicensed global supply, system implementation, and commercial medicines supply chain. Currently, Penny manages the Colonis supply chain, which includes planning, procure to pay, logistics, and new product introduction. She is also an associate member of the Chartered Institute of Purchasing and Supply.
Suzie Stratford – International Business Development Manager
Suzie joined the Colonis team in 2023 as our Alliance and Business Development Manager. She holds an MA in International Business Management and brings with her four years of pharmaceutical industry experience, having previously focused on licensing deals for value-added and branded generic medicines in a range of therapeutic areas. Suzie is responsible for the management of our international partner network and expanding the Colonis product portfolio into global markets.
With over 15 years of experience in quality control, research development and regulatory affairs, Vamshee has been Colonis’ Regulatory Affairs Director since 2018. He guides product development through European and international regulatory processes and specialises in development strategies, including preparation, planning, and participation in scientific advice meetings with regulatory agencies. Vamshee also offers insights on in-licensing opportunities and acquisitions, leveraging his background as a trained pharmacist.
Yulia joined Colonis as a Market Analyst in 2019, where she specialises in analysing product market competition, forecasting future sales, and conducting scenario modelling and sensitivity analysis.
You are now leaving
You are now leaving the Colonis website and being redirected to a Clinigen Group website.
Click “Cancel” to remain on the Colonis website. Click “Continue” to visit the Clinigen website.